Modulation of the glutamate-evoked release of arachidonic acid from mouse cortical neurons: involvement of a pH-sensitive membrane phospholipase A2

J Neurosci. 1995 May;15(5 Pt 1):3307-17. doi: 10.1523/JNEUROSCI.15-05-03307.1995.

Abstract

Excitatory synaptic transmission is associated with changes in both extracellular and intracellular pH. Using mouse cortical neurons in primary cultures, we studied the sensitivity of glutamate-evoked release of 3H-arachidonic acid (3H-AA) to changes in extracellular pH (pHo) and related intracellular pH (pHi). As pHo was shifted from 7.2 to 7.8, the glutamate-evoked release of 3H-AA was enhanced by approximately threefold. The effect of alkaline pHo on the glutamate response was rapid, becoming significant within 2 min. 3H-AA release, evoked by both NMDA and kainate, was also enhanced by pHo alkalinization. NMDA- and kainate-induced increase in free intracellular Ca2+ was unaffected by changing pHo from 7.2 to 7.8, indicating that the receptor-induced Ca2+ influx is not responsible for the pHo sensitivity of the glutamate-evoked release of 3H-AA. Alkalinization of pHi obtained by incubating neurons in the presence of HCO3- or NH4 enhanced the glutamate-evoked release of 3H-AA, while pHi acidification obtained by blockade of Na+/H+ and Cl-/HCO3- exchangers decreased the glutamate response. Membrane-bound phospholipase A2 (mPLA2) activity was stimulated by Ca2+ in a pH-dependent manner, increasing its activity as pH was shifted from 7.2 to 7.8. This pH profile corresponds to the pH profile of the glutamate-, NMDA- and kainate-evoked release of 3H-AA. Taken together, these results indicate that the glutamate-evoked release of 3H-AA may be mediated by the pH-sensitive mPLA2. Since excitatory neurotransmission mediated by glutamate results in both pHo and pHi changes and since AA enhances glutamatergic neurotransmission at both pre- and postsynaptic levels, the data reported here reveals a possible molecular mechanism whereby glutamate can modulate its own signalling efficacy in a pH-dependent manner by regulating the release of AA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / pharmacology
  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Amiloride / pharmacology
  • Ammonium Chloride / pharmacology
  • Animals
  • Arachidonic Acid / metabolism*
  • Calcium / metabolism
  • Cell Membrane / enzymology
  • Cell Survival
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Cerebral Cortex / metabolism*
  • Dizocilpine Maleate / pharmacology
  • Embryo, Mammalian
  • Female
  • Glutamic Acid / pharmacology*
  • Harmaline / pharmacology
  • Hydrogen-Ion Concentration
  • Immunohistochemistry
  • Kainic Acid / pharmacology
  • Kinetics
  • Kynurenic Acid / pharmacology
  • Mice
  • N-Methylaspartate / pharmacology
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Phospholipases A / metabolism*
  • Phospholipases A2
  • Pregnancy
  • Time Factors
  • Tritium

Substances

  • Ammonium Chloride
  • Tritium
  • Arachidonic Acid
  • Glutamic Acid
  • N-Methylaspartate
  • Dizocilpine Maleate
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • Amiloride
  • Harmaline
  • Phospholipases A
  • Phospholipases A2
  • Kynurenic Acid
  • 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
  • Kainic Acid
  • Calcium